WebCEPTARIS THERAPEUTICS, INC: Street Address 1 Street Address 2; 101 LINDENWOOD DRIVE: SUITE 400: City State/Province/Country ZIP/PostalCode Phone Number of … WebAug 1, 2013 · Stephen Tullman, President and CEO, Ceptaris Therapeutics, Inc. Related news: UPDATE 1-Actelion buys U.S.-based specialty drugmaker Ceptaris (Reuters) Reference links: Actelion press release.

Ception Therapeutics Company Profile Management and …

WebJun 5, 2012 · About Ceptaris Therapeutics Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of … WebApplicant Ceptaris Therapeutics, Inc. Formulation(s) 0.016% gel Dosing Regimen Topical, once daily Indication(s) CTCL Stage IA and IB, second-line therapy Intended Population(s) Adults ≥ 18 years Template Version: March 6, 2009 Reference ID: 3331209. Clinical Review the syndicate series 3 watch online

What We Do - Aquilo Partners

WebNov 20, 2006 · Ceptaris Therapeutics Inc. is a specialty pharmaceutical company that was established to develop a proprietary gel formulation of mechlorethamine for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of CTCL. If approved, Ceptaris' investigational drug would be the first FDA-approved topical mechlorethamine product … WebCeptaris Therapeutics, Inc. produces and distributes pharmaceutical products. The Company offers prescription medications for the treatment of mycosis fungoides type of … WebFunding/Support: This study was supported in part by grant R01 FD003017 from the Office of Orphan Products Development of the Food and Drug Administration (Dr Lessin) and by Ceptaris Therapeutics, Inc. … sephora dartmouth micmac